澳优(01717.HK)料自家品牌配方奶粉产品第三季销售额按年增逾30%
澳优(01717.HK)指,注意到公司股份之价格及成交量今天出现不寻常波动。经就合理查询後,确认并不知悉任何导致股份价格及成交量出现有关波动之原因,亦不知悉任何必须公布之内幕消息。
另外,董事会确认目前集团之财务及营运状况保持理想,过去数年之收入增长预期将持续至截至2019年9月30日止三个月,主要源於集团之自家品牌配方奶粉产品之增长。基於目前取得之资料,预期集团自家品牌配方奶粉产品第三季之销售额将按年增加超过30%。
目前,就杀人鲸资本的沽空报告所作的独立审查第二阶段现正按计划进行。基於独立审查目前之进度,独立审查之第二阶段预期将於今年10月完成。独立审查委员会将於第二阶段完成後审阅独立审查之发现,并据此向董事会推荐应采取之适当行动。公司将於适当时候另行发表公告,向股东及潜在投资者提供有关独立审查第二阶段之进展及主要发现之最新资料。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.